Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
UBS
Cipla
Cerilliant
Merck
Express Scripts
Accenture
Chubb

Generated: May 25, 2018

DrugPatentWatch Database Preview

LENTE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Lente patents expire, and when can generic versions of Lente launch?

Lente is a drug marketed by Novo Nordisk Inc and Lilly and is included in four NDAs.

The generic ingredient in LENTE is insulin zinc susp beef. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin zinc susp beef profile page.
Summary for LENTE
US Patents:0
Applicants:2
NDAs:4
DailyMed Link:LENTE at DailyMed
Drug patent expirations by year for LENTE

US Patents and Regulatory Information for LENTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc LENTE insulin zinc susp purified pork INJECTABLE;INJECTION 018383-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novo Nordisk Inc LENTE INSULIN insulin zinc susp beef INJECTABLE;INJECTION 017998-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly LENTE ILETIN II insulin zinc susp purified beef INJECTABLE;INJECTION 018477-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly LENTE ILETIN II (PORK) insulin zinc susp purified pork INJECTABLE;INJECTION 018347-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Queensland Health
Citi
Cantor Fitzgerald
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.